Comparison of dalbavancin with standard of care in the management of infective endocarditis: efficacy, safety, and cost analysis

Bibliographic Details
Title: Comparison of dalbavancin with standard of care in the management of infective endocarditis: efficacy, safety, and cost analysis
Authors: Milagros Suárez, Antonio Pérez-Landeiro, Ana Sanjurjo, Olalla Lima, Adrián Sousa, Ana López, Lucía Martínez-Lamas, Xurxo Cabrera, Martín Rubianes, María Teresa Pérez-Rodríguez
Source: International Journal of Infectious Diseases, Vol 138, Iss , Pp 41-45 (2024)
Publisher Information: Elsevier, 2024.
Publication Year: 2024
Collection: LCC:Infectious and parasitic diseases
Subject Terms: Infective endocarditis, Sequential therapy, Dalbavancin, Cost analysis, Infectious and parasitic diseases, RC109-216
More Details: Objectives: Due to its long half-life, dalbavancin offers benefits for long-duration treatments, especially osteoarticular and infective endocarditis (IE). We evaluated the efficacy and costs of IE treatment, comparing dalbavancin with standard of care (SOC). Methods: Retrospective multicenter cohort study of adult patients with Gram-positive cocci definite IE. Dalbavancin was used as a sequential therapy before discharge. Efficacy was a combined variable of clinical cure and absence of recurrence in 12-month follow-up. Length of hospital stay and the associated costs were analyzed in both groups of treatment. Results: Twenty-two patients received dalbavancin and 47 SOC. The efficacy was similar between the groups (dalbavancin 18 [72%] vs SOC 44 [94%], P = 0.198). Hospital stay was shorter in the dalbavancin group (dalbavancin 22 days [16-34] vs SOC 37 days [23-49], P = 0.001), especially in those with E. faecalis IE (dalbavancin 30 days [20-36] vs SOC 65 days [46-74], P
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1201-9712
Relation: http://www.sciencedirect.com/science/article/pii/S1201971223007646; https://doaj.org/toc/1201-9712
DOI: 10.1016/j.ijid.2023.11.003
Access URL: https://doaj.org/article/7f8f0435666a42acbd809d517e741c37
Accession Number: edsdoj.7f8f0435666a42acbd809d517e741c37
Database: Directory of Open Access Journals
More Details
ISSN:12019712
DOI:10.1016/j.ijid.2023.11.003
Published in:International Journal of Infectious Diseases
Language:English